These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32770268)

  • 1. Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties.
    Ryšánek P; Grus T; Šíma M; Slanař O
    Pharm Res; 2020 Aug; 37(9):166. PubMed ID: 32770268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol.
    Feng W; Qin C; Chu Y; Berton M; Lee JB; Zgair A; Bettonte S; Stocks MJ; Constantinescu CS; Barrett DA; Fischer PM; Gershkovich P
    Eur J Pharm Biopharm; 2021 May; 162():43-49. PubMed ID: 33677067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H; Zhou A; Lu C; Wang L
    Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides.
    Holm R; Porter CJ; Edwards GA; Müllertz A; Kristensen HG; Charman WN
    Eur J Pharm Sci; 2003 Sep; 20(1):91-7. PubMed ID: 13678797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
    Managuli RS; Raut SY; Reddy MS; Mutalik S
    Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analogues.
    Caliph SM; Faassen WA; Vogel GM; Porter CJ
    Curr Drug Deliv; 2009 Aug; 6(4):359-66. PubMed ID: 19534711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.
    Trevaskis NL; Charman WN; Porter CJ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):702-16. PubMed ID: 18155316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs.
    Lespine A; Chanoit G; Bousquet-Melou A; Lallemand E; Bassissi FM; Alvinerie M; Toutain PL
    Eur J Pharm Sci; 2006 Jan; 27(1):37-43. PubMed ID: 16198549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-Based Oral Formulation Strategies for Lipophilic Drugs.
    Patel V; Lalani R; Bardoliwala D; Ghosh S; Misra A
    AAPS PharmSciTech; 2018 Nov; 19(8):3609-3630. PubMed ID: 30255474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
    Franco V; Gershkovich P; Perucca E; Bialer M
    Clin Pharmacokinet; 2020 Dec; 59(12):1493-1500. PubMed ID: 32785853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal lymphatic drug transport: an update.
    Porter CJ; Charman WN
    Adv Drug Deliv Rev; 2001 Aug; 50(1-2):61-80. PubMed ID: 11489334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol.
    Caliph SM; Faassen FW; Porter CJ
    J Pharm Pharmacol; 2014 Oct; 66(10):1377-87. PubMed ID: 24821499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats.
    Zhou A; Lu T; Wang L; Lu C; Wang L; Wan M; Wu H
    Pharm Dev Technol; 2014 Sep; 19(6):743-7. PubMed ID: 23978005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-based formulations for intestinal lymphatic delivery.
    O'Driscoll CM
    Eur J Pharm Sci; 2002 Jun; 15(5):405-15. PubMed ID: 12036717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs.
    Ryšánek P; Grus T; Lukáč P; Kozlík P; Křížek T; Pozniak J; Roušarová J; Královičová J; Kutinová Canová N; Boleslavská T; Bosák J; Štěpánek F; Šíma M; Slanař O
    Br J Pharmacol; 2021 Dec; 178(23):4663-4674. PubMed ID: 34365639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs.
    Khoo SM; Shackleford DM; Porter CJ; Edwards GA; Charman WN
    Pharm Res; 2003 Sep; 20(9):1460-5. PubMed ID: 14567642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intestinal lymphatic transport of breviscapine orally administered in rat].
    Gong YJ; Wang JX; Zhang Y; Shen M; Fu CM; Shen T
    Yao Xue Xue Bao; 2011 Oct; 46(10):1262-7. PubMed ID: 22242462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of oral moxidectin bioavailability in rabbits by lipid co-administration.
    Bassissi MF; Lespine A; Alvinerie M
    Parasitol Res; 2004 Oct; 94(3):188-92. PubMed ID: 15338286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220.
    Gershkovich P; Qadri B; Yacovan A; Amselem S; Hoffman A
    Eur J Pharm Sci; 2007 Aug; 31(5):298-305. PubMed ID: 17560096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.